CeGa T

CeGaT is a global leader in gene diagnostics and mutation-related disease analysis. By pioneering a method that combines gene diagnostics with high-throughput sequencing, CeGaT became the first company to develop so-called diagnostic panels. These panels allow for the first time the mapping and analysis of all genes associated with a particular disease. At the same time, we have launched diagnostic panels for a wide range of disease categories. As a result, CeGaT is able to significantly improve the accuracy and speed of diagnostics, enabling more targeted and effective treatments, better quality of patient care, and significantly reduced costs in the healthcare industry.